This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1073858408319974v1 15/1/28    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Le, W. Articles by Jankovic, J. Search for Related Content PubMed PubMed Citation Articles by Le, W. Articles by Jankovic, J. Social Bookmarking                         What's this?

Etiopathogenesis of Parkinson Disease: A New Beginning?

Department of Neurology, Baylor College of Medicine, Houston, Texas

^* To whom correspondence should be addressed. E-mail: josephj{at}bcm.tmc.edu.

	Abstract

Parkinson disease (PD) probably represents a syndrome of different disorders and origins converging into a relatively uniform neurodegenerative process. Although clinical-pathological studies have suggested that the presymptomatic phase of PD may be relatively short, perhaps less than a decade, the authors postulate that the pathogenic mechanisms may begin much earlier, possibly even in the prenatal period. Thus, some patients with PD may be born with a fewer than normal number of dopaminergic (and nondopaminergic) neurons as a result of genetic or other abnormalities sustained during the prenatal or perinatal period; as a result of normal age-related neuronal attrition, they eventually reach the critical threshold (60% or more) of neuronal loss needed for onset of PD to become clinically manifest. The authors review the emerging evidence that genetic disruption of normal development, coupled with subsequent environmental factors (the so called multiple-hit hypothesis), plays an important role in the etiopathogenesis of PD. NEUROSCIENTIST XX(X):xx–xx, XXXX. DOI: 10.1177/1073858408319974

First published on November 13, 2008, doi:10.1177/1073858408319974

The Neuroscientist 2009;15:28.

A more recent version of this article appeared on February 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Jang, D. Boltz, K. Sturm-Ramirez, K. R. Shepherd, Y. Jiao, R. Webster, and R. J. Smeyne From the Cover: Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration PNAS, August 18, 2009; 106(33): 14063 - 14068. [Abstract] [Full Text] [PDF]

				K. Caradonna and M. PereiraPerrin Preferential Brain Homing following Intranasal Administration of Trypanosoma cruzi Infect. Immun., April 1, 2009; 77(4): 1349 - 1356. [Abstract] [Full Text] [PDF]